Standard Interpretations - (Archived) Table of Contents|
| Standard Number:||1910.1030|
August 28, 1995
Paul Martin Kempen, M.D., Ph.D.
Co-Director Obstetric Anesthesia
Department of Anesthesiology
Louisiana State University Medical Center
P.O. Box 33932
Shreveport, Louisiana 71130-3932
Dear Dr. Kempen:
This is in response to your letter of April 26, addressed to Joseph A. Dear, Assistant Secretary of the Occupational Safety and Health Administration (OSHA), regarding compliance issues and intravenous (IV) drug administration.
Your letter and enclosed article describe your concerns regarding alternatives to direct hypodermic needle injection into latex ports in IV administration. These concerns appear to be based on your stated belief that OSHA and other regulatory agencies "prohibit" this practice and require needleless systems. This, however, as far as OSHA is concerned, is not the case.
The OSHA regulation, 29 CFR 1910.1030 "Occupational Exposure to Bloodborne Pathogens," does not prohibit the use of sharps or require needleless systems. OSHA does, however, require employers to establish an exposure control plan "designed to eliminate or minimize employee exposure." A significant hazard to workers is from needles and other sharp objects contaminated with blood or other potentially infectious materials. OSHA encourages employers to minimize, to the extent feasible, the handling of needles and sharps.
We hope this is responsive to your concerns. Thank you for your interest in worker safety and health.
John B. Miles, Jr. Director
Directorate of Compliance Programs
|Standard Interpretations - (Archived) Table of Contents|
The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.